Rizwan Ali

Dr. Rizwan Ali

Biomedical Engineering, University of Science and Technology, Hefei, Anhui, China
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Qurat ul Ain ZahraQurat ul Ain Zahra
Qurat ul Ain Zahra
ZLZhaofeng Luo
Zhaofeng Luo
Rizwan AliRizwan Ali
Rizwan Ali
MKMuhammad Imran Khan
Muhammad Imran Khan
FLFenfen Li
Fenfen Li
BQBensheng Qiu
Bensheng Qiu
Misuse of antibiotics has recently been considered a global issue because of its harmful effects on human health. Since conventional methods have numerous limitations, it is necessary to develop fast, simple, sensitive, and reproducible methods for the detection of antibiotics. Among numerous recently developed methods, aptasensors are fascinating because of their good specificity, sensitivity and selectivity. These kinds of biosensors combining aptamer with colorimetric applications of gold nanoparticles to recognize small molecules are becoming more popular owing to their advantageous features, for example, low cost, ease of use, on-site analysis ability using naked eye and no prerequisite for modern equipment. In this review, we have highlighted the recent advances and working principle of gold nanoparticles based colorimetric aptasensors as promising methods for antibiotics detection in different food and environmental samples (2011–2020). Furthermore, possible advantages and disadvantages have also been summarized for these methods. Finally, the recent challenges, outlook, and promising future perspectives for developing novel aptasensors are also considered.

1 June 2021 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
XHXiao Lin Huang
Xiao Lin Huang
MKMuhammad Imran Khan
Muhammad Imran Khan
JWJing Wang
Jing Wang
Rizwan AliRizwan Ali
Rizwan Ali
SASyed Wajahat Ali
Syed Wajahat Ali
BQBensheng Qiu
Bensheng Qiu

13 January 2022 in Ceramics International
Verified
Journal Article
Closed access
Rizwan AliRizwan Ali
Rizwan Ali
MAMuhammad Hammad Aziz
Muhammad Hammad Aziz
SGShuang Gao
Shuang Gao
MKMuhammad Imran Khan
Muhammad Imran Khan
FLFenfen Li
Fenfen Li
BQBensheng Qiu
Bensheng Qiu

9 September 2017 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
YZYawen Zhou
Yawen Zhou
RLRuili Li
Ruili Li
XWXiaoxiao Wang
Xiaoxiao Wang
HMHui Miao
Hui Miao
YWYarui Wei
Yarui Wei
HLHongjun Li
Hongjun Li

1 January 2020 in Journal of Radiation Research and Applied Sciences
Verified
Journal Article
Open access
MKMuhammad Imran Khan
Muhammad Imran Khan
SXSurui Xu
Surui Xu
MAMalik Mubashar Ali
Malik Mubashar Ali
Rizwan AliRizwan Ali
Rizwan Ali
AKAhsan Kazmi
Ahsan Kazmi
FLFenfen Li
Fenfen Li
The emerging threat of multi-drug resistance (MDR) in a wide range of diseases is a major public health problem, which prolongs treatment, imposes disabilities and reduces the expected life span. MDR is common in urinary tract infections (UTI). Due to recent dramatic change in antimicrobial activity spectrum, we evaluated the current spectrum of antimicrobials activity in UTIs. We observed 33% infection rate in cultures and positive cultures were followed by the Kirby–Bauer technique for sensitivity testing. We evaluated that females are 3.71 folds more infected than males. We observed Escherichia coli (E. coli) as the most frequent and Pseudomonas aeruginosa (P. aeruginosa) as the least (9.1%). Further, we noted that E. coli infection in males is 4.75 times of males. Moreover, Klebsiella pneumoniae (K. pneumoniae) and E. coli are 2.33 and 7.67 times more prevalent than P. aeruginosa respectively. Our sensitivity results indicate that E. coli and K. pneumoniae are resistant to the most tested antimicrobials. However, P. aeruginosa is susceptible to only few of the tested drugs which include Amikacin, Piperacillin+Tazobactam (in combination), and Ceftriaxone. We conclude, due to MDR strains we need to imitate the current strategies and propose neoadjuvant and other therapies like applied in cancer.

23 August 2022 in Coordination Chemistry Reviews
Verified
Journal Article
Closed access
MKMuhammad Imran Khan
Muhammad Imran Khan
FBFakhra Batool
Fakhra Batool
Rizwan AliRizwan Ali
Rizwan Ali
Qurat ul Ain ZahraQurat ul Ain Zahra
Qurat ul Ain Zahra
WWWenshen Wang
Wenshen Wang
BQBensheng Qiu
Bensheng Qiu